miR-99a

Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer

J. Li, Song, Z. J., Wang, Y. Y., Yin, Y., Liu, Y., Nan, X., Li, J., Song, Z. J., Wang, Y. Y., Yin, Y., Liu, Y., and Nan, X., Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer, vol. 15, p. -, 2016.

MicroRNA (miRNA) deregulation has been previously linked to the initiation and development of breast cancer. Although miR-99a is aberrantly expressed in many types of cancers, including breast cancer, the serum miR-99a expression level in breast cancer and its clinical significance remains unknown. Blood samples were obtained from 72 patients with breast cancer and 40 healthy volunteers, and subjected to real-time polymerase chain reaction to evaluate the level of expression of serum miR-99a in the study participants.

Subscribe to miR-99a